NEPH
Price
$4.15
Change
-$0.05 (-1.19%)
Updated
Sep 3 closing price
Capitalization
43.99M
63 days until earnings call
OFIX
Price
$14.75
Change
-$0.14 (-0.94%)
Updated
Sep 3 closing price
Capitalization
582.54M
63 days until earnings call
Interact to see
Advertisement

NEPH vs OFIX

Header iconNEPH vs OFIX Comparison
Open Charts NEPH vs OFIXBanner chart's image
Nephros
Price$4.15
Change-$0.05 (-1.19%)
Volume$137.85K
Capitalization43.99M
Orthofix Medical
Price$14.75
Change-$0.14 (-0.94%)
Volume$334.52K
Capitalization582.54M
NEPH vs OFIX Comparison Chart in %
Loading...
NEPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OFIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEPH vs. OFIX commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEPH is a Buy and OFIX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (NEPH: $4.15 vs. OFIX: $14.75)
Brand notoriety: NEPH and OFIX are both not notable
NEPH represents the Pharmaceuticals: Other, while OFIX is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: NEPH: 322% vs. OFIX: 83%
Market capitalization -- NEPH: $43.99M vs. OFIX: $582.54M
NEPH [@Pharmaceuticals: Other] is valued at $43.99M. OFIX’s [@Medical/Nursing Services] market capitalization is $582.54M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $158.15B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $230.05B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.75B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.6B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEPH’s FA Score shows that 0 FA rating(s) are green whileOFIX’s FA Score has 1 green FA rating(s).

  • NEPH’s FA Score: 0 green, 5 red.
  • OFIX’s FA Score: 1 green, 4 red.
According to our system of comparison, OFIX is a better buy in the long-term than NEPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEPH’s TA Score shows that 6 TA indicator(s) are bullish while OFIX’s TA Score has 4 bullish TA indicator(s).

  • NEPH’s TA Score: 6 bullish, 4 bearish.
  • OFIX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, NEPH is a better buy in the short-term than OFIX.

Price Growth

NEPH (@Pharmaceuticals: Other) experienced а +2.47% price change this week, while OFIX (@Medical/Nursing Services) price change was -0.61% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.09%. For the same industry, the average monthly price growth was +6.96%, and the average quarterly price growth was +33.57%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.08%. For the same industry, the average monthly price growth was +1.73%, and the average quarterly price growth was +23.90%.

Reported Earning Dates

NEPH is expected to report earnings on Nov 06, 2025.

OFIX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-2.09% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-0.08% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OFIX($583M) has a higher market cap than NEPH($44M). NEPH YTD gains are higher at: 182.313 vs. OFIX (-15.521). OFIX has higher annual earnings (EBITDA): 3.68M vs. NEPH (1.49M). OFIX has more cash in the bank: 65.6M vs. NEPH (5.07M). NEPH has less debt than OFIX: NEPH (1.24M) vs OFIX (205M). OFIX has higher revenues than NEPH: OFIX (809M) vs NEPH (16.7M).
NEPHOFIXNEPH / OFIX
Capitalization44M583M8%
EBITDA1.49M3.68M41%
Gain YTD182.313-15.521-1,175%
P/E Ratio34.58N/A-
Revenue16.7M809M2%
Total Cash5.07M65.6M8%
Total Debt1.24M205M1%
FUNDAMENTALS RATINGS
NEPH vs OFIX: Fundamental Ratings
NEPH
OFIX
OUTLOOK RATING
1..100
8124
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
84
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
5496
PRICE GROWTH RATING
1..100
3641
P/E GROWTH RATING
1..100
1009
SEASONALITY SCORE
1..100
2375

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NEPH's Valuation (66) in the null industry is in the same range as OFIX (84) in the Medical Specialties industry. This means that NEPH’s stock grew similarly to OFIX’s over the last 12 months.

NEPH's Profit vs Risk Rating (100) in the null industry is in the same range as OFIX (100) in the Medical Specialties industry. This means that NEPH’s stock grew similarly to OFIX’s over the last 12 months.

NEPH's SMR Rating (54) in the null industry is somewhat better than the same rating for OFIX (96) in the Medical Specialties industry. This means that NEPH’s stock grew somewhat faster than OFIX’s over the last 12 months.

NEPH's Price Growth Rating (36) in the null industry is in the same range as OFIX (41) in the Medical Specialties industry. This means that NEPH’s stock grew similarly to OFIX’s over the last 12 months.

OFIX's P/E Growth Rating (9) in the Medical Specialties industry is significantly better than the same rating for NEPH (100) in the null industry. This means that OFIX’s stock grew significantly faster than NEPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NEPHOFIX
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
71%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
69%
Advances
ODDS (%)
Bullish Trend 11 days ago
75%
Bullish Trend 9 days ago
71%
Declines
ODDS (%)
Bearish Trend 7 days ago
82%
Bearish Trend 1 day ago
76%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
NEPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OFIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LEGN35.951.73
+5.06%
Legend Biotech Corp
ABT132.180.72
+0.55%
Abbott Laboratories
MTLS4.93-0.02
-0.40%
Materialise NV
AMPH29.39-1.42
-4.61%
Amphastar Pharmaceuticals
JUNS1.24-0.12
-8.82%
Jupiter Neurosciences Inc

NEPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEPH has been loosely correlated with IMDX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NEPH jumps, then IMDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEPH
1D Price
Change %
NEPH100%
-1.19%
IMDX - NEPH
34%
Loosely correlated
-1.54%
SGHT - NEPH
33%
Loosely correlated
-1.81%
NEO - NEPH
25%
Poorly correlated
-7.04%
OFIX - NEPH
22%
Poorly correlated
-0.94%
VNRX - NEPH
22%
Poorly correlated
+0.27%
More

OFIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, OFIX has been loosely correlated with TCMD. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if OFIX jumps, then TCMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OFIX
1D Price
Change %
OFIX100%
-0.94%
TCMD - OFIX
57%
Loosely correlated
-1.56%
TWST - OFIX
48%
Loosely correlated
-0.91%
ENOV - OFIX
47%
Loosely correlated
-0.58%
BLFS - OFIX
46%
Loosely correlated
-1.18%
MMSI - OFIX
45%
Loosely correlated
-0.65%
More